These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3053566)

  • 1. Mechanism of action of spiramycin and other macrolides.
    Brisson-Noël A; Trieu-Cuot P; Courvalin P
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():13-23. PubMed ID: 3053566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin.
    Poulsen SM; Kofoed C; Vester B
    J Mol Biol; 2000 Dec; 304(3):471-81. PubMed ID: 11090288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of streptogramins and macrolides.
    Vannuffel P; Cocito C
    Drugs; 1996; 51 Suppl 1():20-30. PubMed ID: 8724813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of genotypes that determine resistance to macrolides, lincosamides, and streptogramins B compared with spiramycin susceptibility among erythromycin-resistant Staphylococcus epidermidis.
    Juda M; Chudzik-Rzad B; Malm A
    Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):155-60. PubMed ID: 27008373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome.
    Tenson T; Lovmar M; Ehrenberg M
    J Mol Biol; 2003 Jul; 330(5):1005-14. PubMed ID: 12860123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative in vitro bacteriostatic and bactericidal effect of 5 macrolides: roxithromycin, erythromycin, oleandomycin, josamycin and spiramycin against 284 hospital bacterial strains].
    Le Noc P; Croize J; Bryskier A; Le Noc D; Robert J
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):553-9. PubMed ID: 2797879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses.
    Arthur M; Brisson-Noël A; Courvalin P
    J Antimicrob Chemother; 1987 Dec; 20(6):783-802. PubMed ID: 3326871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transduction of resistance to some macrolide antibiotics in Staphylococcus aureus.
    PATTEE PA; BALDWIN JN
    J Bacteriol; 1962 Nov; 84(5):1049-55. PubMed ID: 13941896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
    Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
    Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin, carbomycin, and spiramycin inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes.
    Menninger JR; Otto DP
    Antimicrob Agents Chemother; 1982 May; 21(5):811-8. PubMed ID: 6179465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the in vitro post-antibiotic effect of C14 macrolides (erythromycin and roxithromycin) and C16 macrolides (josamycin and spiramycin) against Staphylococcus aureus].
    Rolin O; Bouanchaud DH
    Pathol Biol (Paris); 1989 May; 37(5):375-7. PubMed ID: 2780094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Macrolides, lincosamides, streptogramines (MLS): mechanisms of action and resistance].
    Ungureanu V
    Bacteriol Virusol Parazitol Epidemiol; 2010; 55(2):131-8. PubMed ID: 21553477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in streptogramin research.
    Barrière JC; Berthaud N; Beyer D; Dutka-Malen S; Paris JM; Desnottes JF
    Curr Pharm Des; 1998 Apr; 4(2):155-80. PubMed ID: 10197038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of action of 9-O-arylalkyloxime derivatives of 6-O-mycaminosyltylonolide, a new class of 16-membered macrolide antibiotics.
    Karahalios P; Kalpaxis DL; Fu H; Katz L; Wilson DN; Dinos GP
    Mol Pharmacol; 2006 Oct; 70(4):1271-80. PubMed ID: 16873579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes.
    Di Giambattista M; Engelborghs Y; Nyssen E; Cocito C
    J Biol Chem; 1987 Jun; 262(18):8591-7. PubMed ID: 3110150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin.
    FINLAND M; JONES WF; NICHOLS RL
    Proc Soc Exp Biol Med; 1956 Nov; 93(2):388-93. PubMed ID: 13379520
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular basis of resistance to macrolides, lincosamides and streptogramins in Staphylococcus hominis strains isolated from clinical specimens.
    Szczuka E; Makowska N; Bosacka K; Słotwińska A; Kaznowski A
    Folia Microbiol (Praha); 2016 Mar; 61(2):143-7. PubMed ID: 26253583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrolide-lincosamide-resistant phenotypes and genotypes of Staphylococcus aureus isolated from bovine clinical mastitis.
    Wang Y; Wu CM; Lu LM; Ren GW; Cao XY; Shen JZ
    Vet Microbiol; 2008 Jul; 130(1-2):118-25. PubMed ID: 18272297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemistry and mode of action of macrolides.
    Mazzei T; Mini E; Novelli A; Periti P
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():1-9. PubMed ID: 7683018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.